293 related articles for article (PubMed ID: 31720408)
21. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
[TBL] [Abstract][Full Text] [Related]
22. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN
PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389
[TBL] [Abstract][Full Text] [Related]
23. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
24. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
25. Community- based Active Tuberculosis Case Finding in Pastoralist Communities of North-Eastern Uganda.
Isaac G; Robert EJ; Swabrah N; Gloria N; Okungura PD; Oboth P; Iramiot JS; Nekaka R
Microbiol Res J Int; 2019 Nov; 29(3):1-10. PubMed ID: 34169184
[TBL] [Abstract][Full Text] [Related]
26. Impact of active case-finding for tuberculosis on case-notifications in Blantyre, Malawi: A community-based cluster-randomised trial (SCALE).
Feasey HRA; Khundi M; Soko RN; Bottomley C; Chiume L; Burchett HED; Nliwasa M; Twabi HH; Mpunga JA; MacPherson P; Corbett EL
PLOS Glob Public Health; 2023; 3(12):e0002683. PubMed ID: 38051717
[TBL] [Abstract][Full Text] [Related]
27. Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
Lee HN; Kim JI; Kim YH
PLoS One; 2021; 16(5):e0250616. PubMed ID: 33939723
[TBL] [Abstract][Full Text] [Related]
28. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
[TBL] [Abstract][Full Text] [Related]
29. Mobilising community networks for early identification of tuberculosis and treatment initiation in Cambodia: an evaluation of a seed-and-recruit model.
Teo AKJ; Prem K; Tuot S; Ork C; Eng S; Pande T; Chry M; Hsu LY; Yi S
ERJ Open Res; 2020 Apr; 6(2):. PubMed ID: 32391397
[TBL] [Abstract][Full Text] [Related]
30. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a population-wide, systematic screening initiative for tuberculosis on Daru island, Western Province, Papua New Guinea.
Dakulala P; Kal M; Honjepari A; Morris L; Rehan R; Akena SP; Codlin AJ; Jadambaa N; Islam T; Yanagawa M; Morishita F
BMC Public Health; 2024 Apr; 24(1):959. PubMed ID: 38575948
[TBL] [Abstract][Full Text] [Related]
32. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
[TBL] [Abstract][Full Text] [Related]
33. Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia.
Jo Y; Kagujje M; Johnson K; Dowdy D; Hangoma P; Chiliukutu L; Muyoyeta M; Sohn H
PLoS One; 2021; 16(9):e0256531. PubMed ID: 34499668
[TBL] [Abstract][Full Text] [Related]
34. Improving TB case notification in northern Uganda: evidence of a quality improvement-guided active case finding intervention.
Karamagi E; Sensalire S; Muhire M; Kisamba H; Byabagambi J; Rahimzai M; Mugabe F; George U; Calnan J; Seyoum D; Birabwa E
BMC Health Serv Res; 2018 Dec; 18(1):954. PubMed ID: 30541533
[TBL] [Abstract][Full Text] [Related]
35. Multidrug Resistant Mycobacterium tuberculosis Among Military and Civilian Personnel seen at a Tertiary Military Hospital, Manila, Philippines (2015-2018).
Velasco JM; Gaurano N; Valderama MT; Nogrado K; Diones PC; Lopez MN; Liao C; Chua D; Develos M; Fernandez S; Macareo L; Swierczewski B
Mil Med; 2020 Aug; 185(7-8):e1106-e1111. PubMed ID: 31915831
[TBL] [Abstract][Full Text] [Related]
36. Tuberculosis active case finding in Cambodia: a pragmatic, cost-effectiveness comparison of three implementation models.
James R; Khim K; Boudarene L; Yoong J; Phalla C; Saint S; Koeut P; Mao TE; Coker R; Khan MS
BMC Infect Dis; 2017 Aug; 17(1):580. PubMed ID: 28830372
[TBL] [Abstract][Full Text] [Related]
37. Digital Chest X-Ray with Computer-aided Detection for Tuberculosis Screening within Correctional Facilities.
Velen K; Sathar F; Hoffmann CJ; Hausler H; Fononda A; Govender S; Lerefolo M; Govender A; Charalambous S
Ann Am Thorac Soc; 2022 Aug; 19(8):1313-1319. PubMed ID: 34914539
[No Abstract] [Full Text] [Related]
38. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
39. A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns.
Donkeng-Donfack VF; Tchatchueng-Mbougua JB; Abanda NN; Ongboulal SM; Djieugoue YJ; Kamdem Simo Y; Mekemnang Tchoupa M; Bekang Angui F; Kuate Kuate A; Mbassa V; Mvondo Abeng Belinga E; Eyangoh S
BMC Infect Dis; 2022 Mar; 22(1):219. PubMed ID: 35246071
[TBL] [Abstract][Full Text] [Related]
40. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
